Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
Lazertinib + Amivantamab for Non-Small Cell Lung Cancer
Recruiting2 awardsPhase 3
Boston, Massachusetts
This trial is testing a new, easier to use formulation of amivantamab, which has the potential to reduce administration time and improve the patient and physician experience.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service